glycopyrrolate 1.5 MG Oral Tablet
glycopyrrolate
RxCUI: 1247658
What the CMS Formulary Data Shows for glycopyrrolate 1.5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, glycopyrrolate 1.5 MG Oral Tablet (RxNorm concept RXCUI 1247658, generic name glycopyrrolate) appears on 4 distinct formulary files spanning 117 Medicare Part D plan offerings - 2.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.5.
Real-world access to glycopyrrolate 1.5 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 51,524 Part D beneficiaries filled glycopyrrolate 1.5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $11,621,261 and an average per-beneficiary annual cost of $225.55. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry glycopyrrolate 1.5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 117
- Coverage rate
- 2.3%
- Tier range
- Tier 1 – Tier 2
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 51,524
- Total spending
- $11,621,261
- Avg per beneficiary
- $225.55
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering glycopyrrolate 1.5 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is glycopyrrolate 1.5 MG Oral Tablet covered by Medicare Part D?
Yes, glycopyrrolate 1.5 MG Oral Tablet is covered by 117 Medicare Part D plans (2.3% of all Part D formularies).
What tier is glycopyrrolate 1.5 MG Oral Tablet on Medicare Part D plans?
glycopyrrolate 1.5 MG Oral Tablet averages Tier 1.5 across Part D plans, ranging from Tier 1 to Tier 2.
Does glycopyrrolate 1.5 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for glycopyrrolate 1.5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on glycopyrrolate 1.5 MG Oral Tablet?
In 2023, total Medicare Part D spending on glycopyrrolate 1.5 MG Oral Tablet was $11,621,261, covering 51,524 beneficiaries. The average spend per beneficiary was $225.55.
Read our methodology - how this data is sourced, computed, and verified.